Biocon Q4 profit drops 57%, but biosimilars business shines
Published on: May 8, 2026, 11:12 a.m. | Source: The Hindu Business Line
Biocon's Q4 profit drops 57% due to exceptional items, but biosimilars and generics segments show strong growth.
Dr. Aditya Manke
Dr. Aditya Manke — Expert Robotic & Laparoscopic Cancer Surgeon. Precise care, faster recovery.
Looking for free cloud deployment?
Sign up & get $200 free credit for 60 days to launch your first Droplet or GPU server on DigitalOcean 🚀
Signup Now